Filing Details

Accession Number:
0001209191-15-060844
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-14 20:39:16
Reporting Period:
2015-07-10
Filing Date:
2015-07-14
Accepted Time:
2015-07-14 20:39:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1328143 Adamas Pharmaceuticals Inc ADMS Pharmaceutical Preparations (2834) 421560076
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1027621 D Jonathan Feiber 3000 Sand Hill Road
Suite 3-290
Menlo Park CA 94025
No No Yes No
1129541 Mdv Vii Lp C/O Mohr Davidow Ventures
3000 Sand Hill Road, Suite 3-290
Menlo Park CA 94025
No No Yes No
1250354 J Nancy Schoendorf 3000 Sand Hill Road
Suite 3-290
Menlo Park CA 94025
No No Yes No
1410787 Mdv Ix Lp C/O Mohr Davidow Ventures
3000 Sand Hill Road, Suite 3-290
Menlo Park CA 94025
No No Yes No
1564546 Seventh Mdv Partners, L.l.c. 3000 Sand Hill Road
Suite 3-290
Menlo Park CA 94025
No No Yes No
1573991 Ninth Mdv Partners, L.l.c. 3000 Sand Hill Road
Suite 3-290
Menlo Park CA 94025
No No Yes No
1605837 Mdv Enf Vii (A), L.p. 3000 Sand Hill Road
Suite 3-290
Menlo Park CA 94025
No No Yes No
1605838 Mdv Enf Vii (B), L.p. 3000 Sand Hill Road
Suite 3-290
Menlo Park CA 94025
No No Yes No
1605840 Mdv Vii Leaders' Fund, L.p. 3000 Sand Hill Road
Suite 3-290
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-07-10 8,657 $27.53 287,992 No 4 S Indirect MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,772,686 Indirect MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Common Stock 265,150 Indirect MDV VII, L.P.
Common Stock 6,043 Indirect MDV ENF VII (A), L.P.
Common Stock 3,146 Indirect MDV ENF VII (B), L.P.
Common Stock 25,661 Indirect MDV VII Leaders' Fund, L.P.
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by MDV IX on December 15, 2014.
  2. Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $27.50 and $27.68 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, "MDV IX"). William Ericson ("Ericson") and Jonathan Feiber ("Feiber") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX. Each Reporting Person disclaims beneficial ownership of the shares held by MDV IX except to the extent of any pecuniary interest therein. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports.
  4. Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, "MDV VII"). Feiber and Nancy Schoendorf ("Schoendorf") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports.